Fareon, Inc.
About Fareon, Inc.
Fareon, Inc. (formerly Humanity Neurotech) is a clinical-stage medical device company developing biophysics-based therapies targeting neuroinflammation and mitochondrial dysfunction for psychiatric and neurological brain disorders. The company is pioneering non-drug Microtesla Magnetic Therapy to support brain repair and recovery without systemic side effects. It is initially focusing on cognitive impairment from Long COVID and plans platform expansion into other conditions. Fareon is headquartered in San Francisco, CA and operates as a privately held biotechnology research company.
- 🔗 Fareon 2026 Company Profile: Valuation, Funding & Investors | PitchBook
- 🔗 Fareon - One Mind
- 🔗 Particular Ventures investment portfolio | PitchBook
- 🔗 New magnetic therapy could transform treatment of neuroinflammation—a hidden driver of brain disease - Sanford Burnham Prebys
- 🔗 Treating the root cause of brain disorders with physics — Fareon
Key highlights
- Formerly Humanity Neurotech, rebranded and advancing non-invasive magnetic therapy for brain disorders.
- Published research in iScience (Cell Press) showing anti-inflammatory and neuroprotective effects.
- Initial clinical focus on Long COVID-related cognitive impairment with plans for broader neurological applications.
- Backed by health-focused VCs and angel groups including Giant Step Capital and HealthTech Capital.
- 7 employees and led by Founder & CEO Blake Gurfein.
Ask StreetZero about Fareon, Inc.
Put our AI to work on this deal.
Similar companies
Other Other Technology deals, ranked by Signal.
Source document & SEC filing
The source SEC filing and the cached document are available to members only. Sign in to view and download them.
Sign in to view the filing Create free account